Joanna Brewer - May 4, 2022 Form 4 Insider Report for Adaptimmune Therapeutics PLC (ADAP)

Role
Chief Scientific Officer
Signature
/s/ Joanna Brewer
Stock symbol
ADAP
Transactions as of
May 4, 2022
Transactions value $
$0
Form type
4
Date filed
5/4/2022, 09:03 PM
Next filing
Jan 17, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADAP Option to purchase Ordinary Shares Award $0 +334K $0.00 334K May 4, 2022 Ordinary Shares 334K $0.30 Direct F1, F2
transaction ADAP Option to purchase Ordinary Shares Award $0 +224K $0.00 224K May 4, 2022 Ordinary Shares 224K $0.00 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price was converted from GBP0.24 based on an exchange rate of U.S.$1.2513 to GBP1.00. The actual exercise price will be the pounds sterling amount.
F2 Exercisable as to 83,448 Ordinary Shares on May 4, 2023 and will be exercisable as to the remainder in monthly installments of 6,954 Ordinary Shares on the fourth of each month from June 4, 2023 through May 4, 2026.
F3 The exercise price was converted from GBP0.001, being the nominal value of an ordinary share, based on an exchange rate of U.S.$1.2513 to GBP1.00. The actual exercise price will be the pounds sterling amount.
F4 Exercisable as to 55,878 Ordinary Shares on May 4, 2023 and will be exercisable as to the remainder in annual installments of 55,878 Ordinary Shares on the fourth of each May from May 4, 2024 through May 4, 2026.